These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 39134941)

  • 1. Tracing the origin of NDM-1-producing and extensively drug-resistant Pseudomonas aeruginosa ST357 in the Netherlands.
    Rossel CAJ; Hendrickx APA; van Alphen LB; van der Horst RPJ; Janssen AHJW; Kooyman CC; Heddema ER
    BMC Infect Dis; 2024 Aug; 24(1):817. PubMed ID: 39134941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular surveillance of carbapenemase-producing
    Schäfer E; Malecki M; Tellez-Castillo CJ; Pfennigwerth N; Marlinghaus L; Higgins PG; Mattner F; Wendel AF
    Antimicrob Resist Infect Control; 2019; 8():208. PubMed ID: 31893042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Characterization of the First Emerged NDM-1-Producing
    Hong JS; Song W; Park MJ; Jeong S; Lee N; Jeong SH
    Microb Drug Resist; 2021 Aug; 27(8):1063-1070. PubMed ID: 33332204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome analyses of colistin-resistant high-risk bla
    Talat A; Khan F; Khan AU
    BMC Microbiol; 2024 May; 24(1):174. PubMed ID: 38769479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenemase -producing Pseudomonas aeruginosa isolates from Turkey: first report of P. aeruginosa high-risk clones with VIM-5- and IMP-7-type carbapenemases in a tertiary hospital.
    Çekin ZK; Dabos L; Malkoçoğlu G; Fortineau N; Bayraktar B; Iorga BI; Naas T; Aktaş E
    Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115174. PubMed ID: 32980808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Characterization of Carbapenemase-Producing Pseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread of Extensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-β-Lactamase.
    Papagiannitsis CC; Medvecky M; Chudejova K; Skalova A; Rotova V; Spanelova P; Jakubu V; Zemlickova H; Hrabak J;
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National surveillance pilot study unveils a multicenter, clonal outbreak of VIM-2-producing Pseudomonas aeruginosa ST111 in the Netherlands between 2015 and 2017.
    Pirzadian J; Persoon MC; Severin JA; Klaassen CHW; de Greeff SC; Mennen MG; Schoffelen AF; Wielders CCH; Witteveen S; van Santen-Verheuvel M; Schouls LM; Vos MC;
    Sci Rep; 2021 Oct; 11(1):21015. PubMed ID: 34697344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic insights into NDM-1-producing Pseudomonas aeruginosa: Current status in a Bulgarian tertiary hospital and on the Balkans.
    Strateva T; Keuleyan E; Peykov S
    Acta Microbiol Immunol Hung; 2024 Jul; 71(2):99-109. PubMed ID: 38857113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to ceftazidime-avibactam and other new β-lactams in
    Valzano F; La Bella G; Lopizzo T; Curci A; Lupo L; Morelli E; Mosca A; Marangi M; Melfitano R; Rollo T; De Nittis R; Arena F
    Microbiol Spectr; 2024 Aug; 12(8):e0426623. PubMed ID: 38934607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceftazidime/avibactam resistance is associated with PER-3-producing ST309 lineage in Chilean clinical isolates of non-carbapenemase producing
    Soto KD; Alcalde-Rico M; Ugalde JA; Olivares-Pacheco J; Quiroz V; Brito B; Rivas LM; Munita JM; García PC; Wozniak A
    Front Cell Infect Microbiol; 2024; 14():1410834. PubMed ID: 38903939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected mechanisms of resistance in Dutch Pseudomonas aeruginosa isolates collected during 14 years of surveillance.
    Croughs PD; Klaassen CHW; van Rosmalen J; Maghdid DM; Boers SA; Hays JP; Goessens WHF;
    Int J Antimicrob Agents; 2018 Sep; 52(3):407-410. PubMed ID: 29772393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of cefiderocol against carbapenemase-producing and meropenem-non-susceptible Gram-negative bacteria collected in the Japan Antimicrobial Resistant Bacterial Surveillance.
    Kayama S; Kawakami S; Kondo K; Kitamura N; Yu L; Hayashi W; Yahara K; Sugawara Y; Sugai M
    J Glob Antimicrob Resist; 2024 Sep; 38():12-20. PubMed ID: 38789082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying bla
    PÉrez-VÁzquez M; Sola-Campoy PJ; Zurita ÁM; Ávila A; GÓmez-Bertomeu F; SolÍs S; LÓpez-Urrutia L; GÓnzalez-BarberÁ EM; Cercenado E; Bautista V; Lara N; Aracil B; Oliver A; Campos J; Oteo-Iglesias J;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106026. PubMed ID: 32450200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome Sequencing.
    Cabot G; López-Causapé C; Ocampo-Sosa AA; Sommer LM; Domínguez MÁ; Zamorano L; Juan C; Tubau F; Rodríguez C; Moyà B; Peña C; Martínez-Martínez L; Plesiat P; Oliver A
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7415-7423. PubMed ID: 27736752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.
    Mustafa MH; Chalhoub H; Denis O; Deplano A; Vergison A; Rodriguez-Villalobos H; Tunney MM; Elborn JS; Kahl BC; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6735-6741. PubMed ID: 27572406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
    Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal sepsis due to NDM-1 and VIM-2 co-producing Pseudomonas aeruginosa in Morocco.
    Daaboul D; Osman M; Kassem II; Yassine I; Girlich D; Proust A; Mounir C; Zerouali K; Raymond J; Naas T; Oueslati S
    J Antimicrob Chemother; 2024 Jul; 79(7):1614-1618. PubMed ID: 38804143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study.
    McCracken MG; Adam HJ; Blondeau JM; Walkty AJ; Karlowsky JA; Hoban DJ; Zhanel GG; Mulvey MR;
    J Antimicrob Chemother; 2019 Aug; 74(Suppl 4):iv32-iv38. PubMed ID: 31505643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian nationwide survey on Pseudomonas aeruginosa from invasive infections: activity of ceftolozane/tazobactam and comparators, and molecular epidemiology of carbapenemase producers.
    Giani T; Arena F; Pollini S; Di Pilato V; D'Andrea MM; Henrici De Angelis L; Bassetti M; Rossolini GM;
    J Antimicrob Chemother; 2018 Mar; 73(3):664-671. PubMed ID: 29216350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dominance of international high-risk clones in carbapenemase-producing
    Pragasam AK; Veeraraghavan B; Anandan S; Narasiman V; Sistla S; Kapil A; Mathur P; Ray P; Wattal C; Bhattacharya S; Deotale V; Subramani K; Peter JV; Hariharan TD; Ramya I; Iniyan S; Walia K; Ohri VC
    Indian J Med Microbiol; 2018; 36(3):344-351. PubMed ID: 30429385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.